These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14220146)

  • 41. [60 YEARS OF FIBRINOLYSIS].
    MARCHAL G
    Hemostase; 1963; 3():101-4. PubMed ID: 14050807
    [No Abstract]   [Full Text] [Related]  

  • 42. [CORRELATIONS BETWEEN CONSTITUTION AND ACTIVITY IN THE CASE OF FIBRINOLYSIS INHIBITORS].
    LOHMANN K; MARKWARDT F; LANDMANN H
    Thromb Diath Haemorrh; 1964 Jan; 10():424-30. PubMed ID: 14113381
    [No Abstract]   [Full Text] [Related]  

  • 43. [COMPARATIVE STUDY ON THE EFFECT OF EPSILON-AMINOCAPROIC ACID, ACETYL-EPSILON-AMINOCAPROIC ACID AND CAPROLACTAM FOR VARIOUS PARAMETERS OF THE FIBRINOLYTIC SYSTEM].
    AUERSWALD W; DOLESCHEL W
    Wien Med Wochenschr; 1965 Feb; 115():102-5. PubMed ID: 14260441
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the antifibrinolytic effect of trypsin--kallikrein inactivator].
    STEICHELE DF; HERSCHLEIN HJ
    Med Welt; 1961 Oct; 42():2170-2. PubMed ID: 13916580
    [No Abstract]   [Full Text] [Related]  

  • 45. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS].
    VAIREL E; LANDE M; LEGER L
    Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753
    [No Abstract]   [Full Text] [Related]  

  • 46. [THE PHARMACOLOGIC PROPERTIES OF A NEW ANTIFIBRINOLYTIC, PARA-AMINOMETHYLBENZOIC ACID].
    MARKWARDT F; HAUSTEIN KO; KLOECKING HP
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():223-33. PubMed ID: 14248348
    [No Abstract]   [Full Text] [Related]  

  • 47. [OBSERVATIONS ON ACTIVATION OF FIBRINOLYSIS IN HEMORRHAGES DUE TO TONSILLECTOMY AND ON CAUSAL TREATMENT WITH EPSILON-AMINOCAPROIC ACID].
    GHILARDI F; VOENA G; BUSCA G
    Ann Laringol Otol Rinol Faringol; 1965; 64():55-63. PubMed ID: 14295928
    [No Abstract]   [Full Text] [Related]  

  • 48. [EPSILON-AMINOCAPROIC ACID (EPSILON-ACS) INHIBITS FIBRINOLYSIS AND HISTAMINE LIBERATION].
    SCHIERIG H
    Dtsch Gesundheitsw; 1964 Feb; 19():406-10. PubMed ID: 14177030
    [No Abstract]   [Full Text] [Related]  

  • 49. [EPSILON-AMINOCAPROIC ACID (EPSILON-ACS) INHIBITS FIBRINOLYSIS AND HISTAMINE LIBERATION].
    SCHIERIG H
    Dtsch Gesundheitsw; 1964 Feb; 19():406-10. PubMed ID: 14179571
    [No Abstract]   [Full Text] [Related]  

  • 50. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS.
    BRODSKY I; ROSS E; REID WO
    Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048
    [No Abstract]   [Full Text] [Related]  

  • 51. [ON THE INHIBITION OF THE ACTIVIZATION OF PROTEOLYTIC ENZYMES IN RAT PANCREATIC HOMOGENATES AND OF ALPHA-CHYMOTRYPSINOGEN BY EPSILON-AMINOCAPROIC ACID AND P-AMINO-METHYL-BENZOIC ACID].
    TRETTIN HJ
    Z Gesamte Inn Med; 1964 Sep; 19():729-30. PubMed ID: 14232734
    [No Abstract]   [Full Text] [Related]  

  • 52. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACID].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M
    Hemostase; 1964 Mar; 4():95-101. PubMed ID: 14188681
    [No Abstract]   [Full Text] [Related]  

  • 53. [PHARMACO THERAPEUTIC ACTIVATION AND INHIBITION OF SPONTANEOUS FIBRINOLYTIC POTENTIAL IN VARIOUS PICTURES OF GYNECOLOGIC PATHOLOGY].
    BERTONE C
    Minerva Ginecol; 1965 Feb; 17():155-67. PubMed ID: 14305663
    [No Abstract]   [Full Text] [Related]  

  • 54. INHIBITION OF FIBRINOLYTIC ACTIVITY OF PLASMIN BY VARIOUS SYNTHETIC INHIBITORS.
    MURAMATU M; ONISHI T; MAKINO S; FUJII S; YAMAMURA Y
    J Biochem; 1965 Mar; 57():450-3. PubMed ID: 14326102
    [No Abstract]   [Full Text] [Related]  

  • 55. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 56. [PROSTATIC TISSUE AND FIBRINOLYTIC-PROTEOLYTIC ACTIVITY].
    FUERSTENBERG HS
    Urol Int; 1965; 19():326-31. PubMed ID: 14316550
    [No Abstract]   [Full Text] [Related]  

  • 57. [FIBRINOLYSIS; CLINICAL APPLICATIONS].
    BOSMAN G
    Folia Med Neerl; 1964 Dec; 7():178-83. PubMed ID: 14265806
    [No Abstract]   [Full Text] [Related]  

  • 58. [THE "STASIS-THROMBELOSTOGRAM". (CLINICAL AND EXPERIMENTAL IMPORTANCE)].
    STACHER A
    Thromb Diath Haemorrh; 1965 Mar; 13():257-91. PubMed ID: 14289627
    [No Abstract]   [Full Text] [Related]  

  • 59. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 60. [APROPOS OF A COMPLEX HEMORRHAGIC SYNDROME TREATED WITH EPSILON-AMINOCAPROIC ACID].
    CROIZAT P; REVOL L; THOUVEREZ ; BELLEVILLE ; BRUNAT
    Lyon Med; 1964 Feb; 211():403-9. PubMed ID: 14141971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.